このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Upexi マネジメント

マネジメント基準チェック /24

現在、CEO に関する十分な情報がありません。

主要情報

Allan Marshall

最高経営責任者

US$1.3m

報酬総額

CEO給与比率	66.1%
CEO在任期間	5.1yrs
CEOの所有権	14.1%
経営陣の平均在職期間	データなし
取締役会の平均在任期間	3.4yrs

経営陣の近況

Recent updates

CEO報酬分析

Upexi の収益と比較して、Allan Marshall の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Dec 31 2023	n/a	n/a	-US$20m
Sep 30 2023	n/a	n/a	-US$14m
Jun 30 2023	US$1m	US$840k	-US$15m
Mar 31 2023	n/a	n/a	-US$3m
Dec 31 2022	n/a	n/a	-US$1m
Sep 30 2022	n/a	n/a	-US$7m
Jun 30 2022	US$5m	US$840k	-US$6m
Mar 31 2022	n/a	n/a	-US$923k
Dec 31 2021	n/a	n/a	US$244k
Sep 30 2021	n/a	n/a	US$3m
Jun 30 2021	US$1m	US$285k	US$3m
Mar 31 2021	n/a	n/a	-US$470k
Dec 31 2020	n/a	n/a	-US$3m
Sep 30 2020	n/a	n/a	-US$5m
Jun 30 2020	US$2m	US$300k	-US$5m

報酬と市場: Allanの総報酬 ($USD 1.27M ) は、 US市場 ($USD 678.50K ) の同規模の企業の平均を上回っています。

報酬と収益: Allanの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Allan Marshall (57 yo)

5.1yrs

在職期間

US$1,271,068

報酬

Mr. Allan J. Marshall is Chief Executive Officer at Upexi, Inc. (formerly known as Grove, Inc.) since May 2019 and has been its Director since May 17, 2019. Mr. Marshall joined the Company as Chief Executi...

取締役

名称	ポジション	在職期間	報酬	所有権
Allan Marshall	CEO, President & Chairman of the Board	5.1yrs	US$1.27m	14.12% $ 1.2m
Andrew Norstrud	CFO & Director	4.4yrs	US$430.00k	1.47% $ 122.2k
Eugene Salkind	Independent Director	3.4yrs	US$148.50k	11.76% $ 978.8k
Thomas Williams	Independent Director	3.4yrs	US$148.50k	データなし
Lawrence Dugan	Independent Director	3.4yrs	US$150.50k	0.13% $ 11.1k

3.4yrs

平均在職期間

57yo

平均年齢

経験豊富なボード: UPXIの取締役会は経験豊富であると考えられます ( 3.4年の平均在任期間)。

Upexi マネジメント

マネジメント 基準チェック /24

主要情報

経営陣の近況

Upexi, Inc., Annual General Meeting, Jun 10, 2024

Insufficient new directors

Upexi, Inc., Annual General Meeting, Jun 26, 2023

CEO, President & Chairman of the Board recently bought US$73k worth of stock

High number of new and inexperienced directors

Upexi, Inc. Appoints Anthony Bazan as Chief Operating Officer

Recent updates

Upexi Provides Update on Filing Form 10Q for March 31, 2024

Upexi, Inc. to Report Q3, 2024 Results on Jun 24, 2024

MFA Holdings Corp., 1000915944 Ontario Inc and Nutraproducts LLC acquired VitaMedica Corporation from Upexi, Inc. (NasdaqCM:UPXI) for $6 million.

Upexi, Inc. announced delayed 10-Q filing

Upexi, Inc., Annual General Meeting, Jun 10, 2024

New major risk - Market cap size

Upexi Receives Letter from Nasdaq Regarding Non-Compliance with the Minimum Bid Price Requirement for Continued Listing on the Nasdaq Capital Market Under Nasdaq Listing Rule 5550(a)(2)

Consensus revenue estimates fall by 17%

Consensus revenue estimates fall by 17%

This Analyst Just Downgraded Their Upexi, Inc. (NASDAQ:UPXI) EPS Forecasts

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Insufficient new directors

Upexi, Inc. Revises Preliminary and Unaudited Financial Guidance for the First Quarter Ended September 30, 2023

Upexi, Inc. announced delayed 10-Q filing

Upexi, Inc. Pet Care Brand, Luckytail, Announces Expansion of Product Line to Include All-Natural Dog Supplements

Amplifyir Inc. acquired 100% stake in Interactive Offers LLC from Upexi, Inc. (NasdaqCM:UPXI) for $1.25 million.

Upexi, Inc. (NASDAQ:UPXI) Doing What It Can To Lift Shares

Upexi, Inc., Annual General Meeting, Jun 26, 2023

Third quarter 2023 earnings released: US$0.11 loss per share (vs US$0.003 loss in 3Q 2022)

Investor sentiment deteriorates as stock falls 16%

Upexi, Inc. announced delayed 10-Q filing

Second quarter 2023 earnings released: EPS: US$0.17 (vs US$0.004 in 2Q 2022)

CEO, President & Chairman of the Board recently bought US$73k worth of stock

First quarter 2023 earnings released: US$0.15 loss per share (vs US$0.033 profit in 1Q 2022)

High number of new and inexperienced directors

Grove, Inc. (NasdaqCM:GRVI) completed the acquisition of E-Core, Inc.

Bloomios, Inc. (OTCPK:BLMS) acquired Infusionz, LLC from Upexi, Inc. (NasdaqCM:UPXI) for $23.5 million.

Upexi, Inc. Files Patent for its Single Click-to-optin Technology

Upexi, Inc. Provides Revenue Guidance for the Fiscal Year 2023

Full year 2022 earnings released: US$0.13 loss per share (vs US$0.25 profit in FY 2021)

Upexi, Inc. Appoints Anthony Bazan as Chief Operating Officer

Investor sentiment deteriorated over the past week

Grove, Inc. (NasdaqCM:GRVI) signed a non-binding LOI to acquire E-Core, Inc.

Investor sentiment improved over the past week

Grove CEO provides company update on sales and beyond

Investor sentiment improved over the past week

Grove, Inc.(NasdaqCM:GRVI) dropped from Russell Microcap Value Index

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Grove, Inc. Provides Revenue Guidance for the Fourth Quarter of 2022

Third quarter 2022 earnings released: US$0.003 loss per share (vs US$0.071 profit in 3Q 2021)

High number of new and inexperienced directors

Grove, Inc. (NasdaqCM:GRVI) acquired Cygnet Online LLC.

Grove, Inc., Annual General Meeting, May 24, 2022

Investor sentiment improved over the past week

Second quarter 2022 earnings: EPS in line with expectations, revenues disappoint

High number of new and inexperienced directors

First quarter 2022 earnings released: EPS US$0.033 (vs US$0.078 loss in 1Q 2021)

Investor sentiment improved over the past week

Why Grove's (NASDAQ:GRVI) Earnings Are Weaker Than They Seem

Full year 2021 earnings released: EPS US$0.25 (vs US$0.53 loss in FY 2020)

Grove, Inc. (NasdaqCM:GRVI) signed a letter of intent to acquire Interactive Offers LLC.

Grove, Inc. (NasdaqCM:GRVI) completed the acquisition of VitaMedica Corporation.

Grove: An Underrated CBD Player

Grove, Inc. (NasdaqCM:GRVI) entered into a non binding letter of intent to acquire VitaMedica Corporation.

Grove, Inc. has completed an IPO in the amount of $11 million.

CEO報酬分析

CEO（最高経営責任者

在職期間

報酬

取締役

平均在職期間

平均年齢

マネジメント基準チェック /24